Recombinant Proteins

BID
p53
LBP
CEA
HLA
TCL
TTC
NPM
MAF
Bax

BID Human

BH3 Interacting Domain Death Agonist Human Recombinant

BID Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 195 amino acids and having a molecular mass of 21.9 kDa.
Shipped with Ice Packs
Cat. No.
BT26613
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless solution.

BID Mouse

BH3 Interacting Domain Death Agonist Mouse Recombinant

BID Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 1-195 amino acids and having a molecular mass of 22 kDa.
Shipped with Ice Packs
Cat. No.
BT26695
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless liquid formulation.

BID Mouse, GST

BH3 Interacting Domain Death Agonist Mouse Recombinant, GST

BID Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 1-195 amino acids and having a molecular mass of 48 kDa.
The Mouse BID is expressed as GST-Tag fusion protein and purified by proprietary chromatographic technique.
Shipped with Ice Packs
Cat. No.
BT26821
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless liquid formulation.

tBID Mouse

Truncated BH3 Interacting Domain Death Agonist Mouse Recombinant

Truncated BID Mouse Recombinant also called BH3-interacting domain death agonist p15 produced in E.Coli is a single, non-glycosylated polypeptide chain containing 61-195 amino acids (135 a.a.) and having a molecular mass of 15.4 kDa.
Shipped with Ice Packs
Cat. No.
BT26938
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless liquid formulation.
Definition and Classification

BH3 interacting-domain death agonist (BID) is a pro-apoptotic member of the Bcl-2 protein family. BID proteins are classified based on their function in apoptosis, specifically their role in mitochondrial outer membrane permeabilization (MOMP) and cytochrome c release .

Biological Properties

Key Biological Properties: BID is a pro-apoptotic protein containing only the BH3 domain. It is involved in the intrinsic pathway of apoptosis .

Expression Patterns: BID is expressed in various tissues, including lymphoid tissues, bone marrow, testis, and skeletal muscle .

Tissue Distribution: BID is found in multiple cell types, including lymphocytes, monocytes, neutrophils, and spermatocytes .

Biological Functions

Primary Biological Functions: BID plays a crucial role in apoptosis by interacting with other Bcl-2 family proteins to induce mitochondrial outer membrane permeabilization and cytochrome c release .

Role in Immune Responses: BID is involved in the regulation of immune responses by mediating apoptosis in immune cells .

Pathogen Recognition: BID’s role in apoptosis helps in the elimination of infected cells, thereby contributing to pathogen recognition and clearance .

Modes of Action

Mechanisms with Other Molecules and Cells: BID interacts with Bax, another Bcl-2 family protein, leading to the insertion of Bax into organelle membranes, primarily the outer mitochondrial membrane .

Binding Partners: BID binds to Bax and Bak, promoting their oligomerization and the formation of pores in the mitochondrial membrane .

Downstream Signaling Cascades: The activation of Bax and Bak by BID leads to the release of cytochrome c and other pro-apoptotic factors, triggering the caspase cascade and apoptosis .

Regulatory Mechanisms

Transcriptional Regulation: The expression of BID is upregulated by the tumor suppressor p53, which is activated in response to cellular stress .

Post-Translational Modifications: BID undergoes cleavage by caspase-8, resulting in the formation of truncated BID (tBID), which translocates to the mitochondria to induce apoptosis .

Applications

Biomedical Research: BID is studied extensively in the context of apoptosis and cancer research. Its role in cell death makes it a target for understanding cancer cell resistance to apoptosis .

Diagnostic Tools: BID expression levels can be used as a biomarker for certain cancers and diseases involving dysregulated apoptosis .

Therapeutic Strategies: Targeting BID and its interactions with other Bcl-2 family proteins is being explored as a therapeutic strategy for cancer treatment .

Role in the Life Cycle

Development: BID is involved in the regulation of apoptosis during development, ensuring the proper elimination of cells .

Aging: Dysregulation of BID and apoptosis can contribute to age-related diseases and conditions .

Disease: BID plays a role in various diseases, including cancer, by regulating apoptosis and cell survival .

© Copyright 2024 Thebiotek. All Rights Reserved.